Literature DB >> 9587064

Autosomal recessive polycystic kidney disease.

K Zerres1, S Rudnik-Schöneborn, C Steinkamm, J Becker, G Mücher.   

Abstract

Autosomal recessive polycystic kidney disease (ARPKD) is a rare inherited disorder which usually becomes clinically manifest in early childhood, although the spectrum of ARPKD is much more variable than generally known. Presentation of ARPKD at later ages and survival into adulthood have been observed in many cases. The responsible gene has been mapped to chromosome 6p. Thus there is no evidence of genetic heterogeneity. The most important indication for DNA diagnosis is the prenatal diagnosis in families with at least one affected child. The critical region has been narrowed with the use of recombinant families of about 4 cM. Several possible candidate genes have been excluded.

Entities:  

Mesh:

Year:  1998        PMID: 9587064     DOI: 10.1007/s001090050221

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  30 in total

1.  Hepatorenal findings in obligate heterozygotes for autosomal recessive polycystic kidney disease.

Authors:  Meral Gunay-Aygun; Baris I Turkbey; Joy Bryant; Kailash T Daryanani; Maya Tuchman Gerstein; Katie Piwnica-Worms; Peter Choyke; Theo Heller; William A Gahl
Journal:  Mol Genet Metab       Date:  2011-09-08       Impact factor: 4.797

2.  Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.

Authors:  Rory J Olson; Katharina Hopp; Harrison Wells; Jessica M Smith; Jessica Furtado; Megan M Constans; Diana L Escobar; Aron M Geurts; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2019-08-19       Impact factor: 10.121

Review 3.  Deciphering physiological role of the mechanosensitive TRPV4 channel in the distal nephron.

Authors:  M Mamenko; O Zaika; N Boukelmoune; R G O'Neil; O Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-10

Review 4.  New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications.

Authors:  Grzegorz Telega; David Cronin; Ellis D Avner
Journal:  Pediatr Transplant       Date:  2013-04-17

5.  A novel model of autosomal recessive polycystic kidney questions the role of the fibrocystin C-terminus in disease mechanism.

Authors:  Patricia Outeda; Luis Menezes; Erum A Hartung; Stacey Bridges; Fang Zhou; Xianjun Zhu; Hangxue Xu; Qiong Huang; Qin Yao; Feng Qian; Gregory G Germino; Terry Watnick
Journal:  Kidney Int       Date:  2017-07-18       Impact factor: 10.612

Review 6.  Role of renal TRP channels in physiology and pathology.

Authors:  Viktor Tomilin; Mykola Mamenko; Oleg Zaika; Oleh Pochynyuk
Journal:  Semin Immunopathol       Date:  2015-09-18       Impact factor: 9.623

7.  Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway.

Authors:  Miguel A Garcia-Gonzalez; Luis F Menezes; Klaus B Piontek; Junya Kaimori; David L Huso; Terry Watnick; Luiz F Onuchic; Lisa M Guay-Woodford; Gregory G Germino
Journal:  Hum Mol Genet       Date:  2007-06-16       Impact factor: 6.150

8.  Genetic analysis of the PKHD1 gene with long-rang PCR sequencing.

Authors:  Yong-Qing Tong; Bei Liu; Chao-Hong Fu; Hong-Yun Zheng; Jian Gu; Hang Liu; Hong-Bo Luo; Yan Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

9.  Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease.

Authors:  Jesús M Banales; Tatyana V Masyuk; Pamela S Bogert; Bing Q Huang; Sergio A Gradilone; Seung-Ok Lee; Angela J Stroope; Anatoliy I Masyuk; Juan F Medina; Nicholas F LaRusso
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

Review 10.  Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies.

Authors:  O Ibraghimov-Beskrovnaya; N Bukanov
Journal:  Cell Mol Life Sci       Date:  2008-02       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.